Field Reimbursement Manager - Neurology (Northeast)

Build our future together: The Field Reimbursement Manager is a critical front-line member of the Regeneron Neurology Field team supporting the successful launch and adoption of an HCP-administered rare disease therapy. You will serve as a reimbursement and access expert across buy & bill, specialty pharmacy and alternate sites of care. In this role, you will support providers throughout all facets of the reimbursement cycle including coverage, coding, product acquisition, available patient support services and site‑of‑care decision making to enable sustained patient access in a competitive rare disease environment. When & where: Field role Location: Boston, (Metro) MA Discover your role: Develop and execute account‑specific access and reimbursement plans that support product launch, optimize site of care (alignment of payer policy + patient needs) and build reimbursement confidence with customers (e.g. MD and staff) & support continued patient access. Proactively educate accounts on patient support services and collaborate with Patient Services to support efficient patient onboarding, therapy initiation and ongoing treatment. Develop collaborative relationships with Sales, Patient Services, Account Directors and Medical to align access strategy and remove barriers to therapy initiation. Partner cross-functionally to ensure consistent, accurate REMS communication and field execution. Support coordination between provider offices, specialty pharmacy and infusion sites. Guide healthcare professionals in resolving access challenges including prior authorizations, denials, appeals and payer site‑of‑care restrictions in a manner that follows Regeneron policies and processes. Anticipate and adapt to evolving launch dynamics, payer policies and distribution pathway changes. Demonstrate proactive planning and time management skills by the efficient and effective coverage of your assigned FRM Territory. Establish relationships with access champions (providers, administrators, office staff, financial coordinators) to support access readiness and ongoing therapy delivery. Proactively update customer on payer policy evolution, coding updates (e.g. J‑code progression), and site‑of‑care management trends. This role requires: A bachelor's degree and at least 5 years of experience in the biopharma reimbursement, market access or field-based access roles working in a matrix environment with at least 2 years direct Reimbursement experience supporting medical benefit therapies (buy & bill preferred). We are also expecting you to have experience across buy & bill and specialty pharmacy distribution models, including white bagging and site of care management. Rare disease and experience supporting product launches strongly preferred. Benefits: We have an inclusive culture that provides comprehensive benefits, which vary by location. In the U.S., benefits may include health and wellness programs (including medical, dental, vision, life, and disability insurance), fitness centers, 401(k) company match, family support benefits, equity awards, annual bonuses, paid time off, and paid leaves (e.g., military and parental leave) for eligible employees at all levels! Salary Range (annually) $165,600.00 - $209,600.00 Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, nationality, national or ethnic origin, civil status, age, citizenship status, membership of the Traveler community, sexual orientation, disability, genetic information, familial status, marital or registered civil partnership status, pregnancy or parental status, gender identity, gender reassignment, military or veteran status, or any other protected characteristic in accordance with applicable laws and regulations. The Company will also provide reasonable accommodation to the known disabilities or chronic illnesses of an otherwise qualified applicant for employment, unless the accommodation would impose undue hardship on the operation of the Company's business. #J-18808-Ljbffr Initial Therapeutics, Inc.